Skip to content

Ardelyx ARDX Cash ratio

Cash ratio at other companies

Amgen logo
AmgenAMGN
0.0×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.3×0.0×
AbbVie logo
AbbVieABBV
0.2×+0.1×
XER
Xeris Biopharma Holdings, Inc.XERS
0.9×+0.3×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
0.4×-0.2×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.3×-0.1×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's cash ratio?
Ardelyx (ARDX) reported cash ratio of 0.3× in Q1 2026.
How has Ardelyx's cash ratio changed year-over-year?
Ardelyx's cash ratio decreased by 29.9% year-over-year, from 0.4× to 0.3×.
What is the long-term trend for Ardelyx's cash ratio?
Over 5 years (2020 to 2025), Ardelyx's cash ratio has grown at a -24.9% compound annual growth rate (CAGR), from 3.2× to 0.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.